![Open access](/images/ico/o.png)
![](/images/ico/ico5.png)
Author: Al-Hujaily Ensaf M. Oldham Robyn A. A. Hari Parameswaran Medin Jeffrey A.
Publisher: MDPI
E-ISSN: 1422-0067|17|9|1506-1506
ISSN: 1422-0067
Source: International Journal of Molecular Sciences, Vol.17, Iss.9, 2016-09, pp. : 1506-1506
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/o.png)
![](/images/ico/ico5.png)
The Role of Immunotherapy in Multiple Myeloma
By Kocoglu Mehmet Badros Ashraf
Pharmaceuticals, Vol. 9, Iss. 1, 2016-01 ,pp. :
![](/images/ico/o.png)
![](/images/ico/ico5.png)
Tyrosine Kinase Inhibitors as Antiangiogenic Drugs in Multiple Myeloma
Pharmaceuticals, Vol. 3, Iss. 4, 2010-04 ,pp. :
![](/images/ico/o.png)
![](/images/ico/ico5.png)
Clinical Use of Proteasome Inhibitors in the Treatment of Multiple Myeloma
By Merin Noah M. Kelly Kevin R.
Pharmaceuticals, Vol. 8, Iss. 1, 2014-12 ,pp. :
![](/images/ico/o.png)
![](/images/ico/ico5.png)